Inferra AIResearch Tools

Inferra AI / Company / CLX

Clorox

CLX · Consumer Staples

Last earnings Aug 3, 2026  ·  Next earnings Nov 2, 2026

Key results

Gross marginquarter

41.3%

Gross margin decreased 520 basis points to 41.3% from 46.5%, primarily driven by lower volume, impact from the inventory step-up of the GOJO acquisition, higher commodity costs and higher manufacturing and logistics costs, partially offset by cost savings.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

EPSquarter

50%

Diluted net earnings per share (diluted EPS) decreased 50% to $1.34 from $2.68 in the year-ago quarter.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

Adjusted EPS 1 decreased 42% to $1.66 from $2.87 in the year-ago quarter, primarily due to lower net sales and lower gross margin.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

Gross margin decreased 290 basis points to 42.3% from 45.2% in the year-ago period, primarily driven by lower net sales and higher manufacturing and logistics costs, partially offset by cost savings.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

Diluted EPS decreased 26% to $4.81 from $6.52 in the year-ago period, which includes lapping the cyberattack insurance recovery benefit from the prior period, GOJO transaction-related costs primarily related to inventory step-up and integration costs

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

EPSfull-year

28%

In comparison to the higher base in fiscal year 2025, this results in a year-over-year reduction of about 28% to fiscal year 2026 diluted earnings per share and about 23% to fiscal year 2026 adjusted earnings per share.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

Revenuequarter

13.1%

Supplemental Unaudited Condensed Information Adjusted Free Cash Flow Fiscal Year Adjusted Free Cash Flow Reconciliation Dollars in Millions and percentages based on rounded numbers Fiscal year 2026 Fiscal year 2025 Net cash provided by operations GAAP $612 $981 Less Capital expenditures (207) (220) Add Venture agreement termination payment (2) 476 Adjusted Free cash flow non-GAAP (1) $881 $761 Free cash flow as a percentage of net sales non-GAAP (1) 13.1% 10.7% Net sales $6,720 $7,104 (1) In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most closely related GAAP measure.

SEC original ↗Clorox — Presentation / slide deck (8-K exhibit)EX-99Aug 3, 2026

AI analysis

Q2 2025 · reported Aug 3, 2026

Based on: Earnings release + Q2 2025 deck + parent 8-K + 10-Q — transcript not held

Gross margin · Q2 2025
41.3%
EX-99 · Aug 3, 2026

Headline figures

MetricQ2 2025Prior qtrYear ago
Gross margin41.3%——
EPS50%——
Revenue13.1%——

EX-99 · Aug 3, 2026

Guidance · company-stated

sales

“are expected to increase about 3.5% to 4.5%”

Gross margin

“is expected to be about 42%”

effective tax rate

“is expected to be about 23%”

Diluted EPS

“is expected to be between $5.41 and $5.71”

Adjusted EPS

“is expected to be between $5.70 and $6.00”

Net sales

“growth (decrease) (GAAP) 0 %”

Diluted earnings per share

“Low High As estimated (GAAP) $ 5.41”

Guidance stated in the release for fiscal year 2027; figures as stated.

Next earningsNov 2, 2026Verified from the company’s own announcement

Margin

Gross margin41.3%

Capital allocation

Capex$86M
Revenue13.1%

Management uses free cash flow and free cash flow as a percentage of net sales to help assess the cash generation ability of the business and funds available for investing activities, such as acquisitions, investing in the business to drive growth and financing activities, including debt payments, dividend payments and stock repurchases.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook Delivers Q4 results in line with expectations while advancing strategic investments

Based on: Earnings release + Q2 2025 deck + parent 8-K + 10-Q — transcript not held

Guidance & outlook

sales: “sales are expected to increase about 3.5% to 4.5%”

Gross margin: “Gross margin is expected to be about 42%”

effective tax rate: “effective tax rate is expected to be about 23%”

Diluted EPS: “Diluted EPS is expected to be between $5.41 and $5.71”

Adjusted EPS: “Adjusted EPS is expected to be between $5.70 and $6.00”

Net sales: “Net sales growth (decrease) (GAAP) 0 %”

Diluted earnings per share: “Diluted earnings per share Low High As estimated (GAAP) $ 5.41”

sales (“fiscal year 2027”)
“Organic sales are expected to increase about 3.5% to 4.5%, including more than 3.5 points of benefit from lapping the ERP-related drawdown in the prior fiscal year.”

Gross margin (“fiscal year 2027”)
“Gross margin is expected to be about 42%, reflecting higher-than-normal inflationary headwinds and negative mix more than offsetting the benefits from cost savings.”

effective tax rate (“fiscal year 2027”)
“The company's effective tax rate is expected to be about 23%.”

Diluted EPS (“fiscal year 2027”)
“Diluted EPS is expected to be between $5.41 and $5.71, a year-over-year increase of 12% to 19%, respectively.”

Adjusted EPS (“fiscal year 2027”)
“Adjusted EPS is expected to be between $5.70 and $6.00, or an increase between 3% and 8%, respectively.”

Net sales (“full year Fiscal year 2027”)
“(percentage change versus the year-ago period) Fiscal year 2025 full year Fiscal year 2026 full year Fiscal year 2027 full year outlook Impact Impact Low High Net sales growth (decrease) (GAAP) 0 % (5) % 13 % 14 % Add (Subtract) Divestitures acquisitions 5 (3) (9.5) (9.5) Organic sales growth (decrease) (non-GAAP) 5 % (8) % 3.5 % 4.5 % Page 4 of 17 Note A”

Diluted earnings per share (“Full year 2027”)
“(70) Digital capabilities and productivity enhancements investment 30 59 111 Adjusted EBIT $ 318 $ 460 $ 1,030 $ 1,316 Full year 2027 outlook (estimated range) Diluted earnings per share Low High As estimated (GAAP) $ 5.41 $ 5.71 Acquisition and integration costs (1) 0.29 0.29 As adjusted (Non-GAAP) $ 5.70 $ 6.00 (1) In fiscal year 2027, the company expects to incur approximately”

Guidance stated in the release for fiscal year 2027; figures as stated.

Capital allocation

Management uses free cash flow and free cash flow as a percentage of net sales to help assess the cash generation ability of the business and funds available for investing activities, such as acquisitions, investing in the business to drive growth and financing activities, including debt payments, dividend payments and stock repurchases.

SEC original ↗Clorox — Presentation / slide deck (8-K exhibit)EX-99Aug 3, 2026

Supplemental Unaudited Condensed Information Cash Flow For the quarter ended June 30, 2026 Capital expenditures for the fourth quarter were $86 million versus $75 million in the year-ago quarter (Fiscal year 2026 $207 million).

SEC original ↗Clorox — Presentation / slide deck (8-K exhibit)EX-99Aug 3, 2026

Supplemental Unaudited Condensed Information Adjusted Free Cash Flow Fiscal Year Adjusted Free Cash Flow Reconciliation Dollars in Millions and percentages based on rounded numbers Fiscal year 2026 Fiscal year 2025 Net cash provided by operations GAAP $612 $981 Less Capital expenditures (207) (220) Add Venture agreement termination payment (2) 476 Adjusted Free cash flow non-GAAP (1) $881 $761 Free cash flow as a percentage of net sales non-GAAP (1) 13.1% 10.7% Net sales $6,720 $7,104 (1) In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most closely related GAAP measure.

SEC original ↗Clorox — Presentation / slide deck (8-K exhibit)EX-99Aug 3, 2026

Adjusted free cash flow does not represent cash available only for discretionary expenditures since the Company has mandatory debt service requirements and other contractual and non-discretionary expenditures.

SEC original ↗Clorox — Presentation / slide deck (8-K exhibit)EX-99Aug 3, 2026

DEBT Short-term borrowings As of March 31, 2026, the Company had outstanding $ 1,591 of Notes and loans payable primarily comprised of U.

SEC original ↗Clorox — 10-Q Quarterly report10-QApr 30, 2026

commercial paper borrowings to finance the previously announced GOJO Industries, Inc.

SEC original ↗Clorox — 10-Q Quarterly report10-QApr 30, 2026

Strategy & priorities

htm EX-99.1 Document Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook Delivers Q4 results in line with expectations while advancing strategic investments OAKLAND, California, Aug.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

Even so, we are starting the year from a stronger position to execute our strategy with discipline, build on the momentum we've created and deliver greater superiority across our portfolio.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

Strategic and Operational Highlights The following are highlights of business achievements for fiscal year 2026 Completed the acquisition of GOJO, unlocking new growth synergies across the combined portfolio of Clorox Purell and Clorox Professional by bringing together complementary brands and capabilities to strengthen the company's health and hygiene platform.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

and its trading partners, especially China, the potential expansion of sanctions regimes, and disruptions to global markets or transportation routes, particularly due to the imposition of U.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

The company uses this measure to assess the operating results and performance of its segments, perform analytical comparisons, identify strategies to improve performance, and allocate resources to each segment.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

Risks & headwinds

Gross margin is expected to be about 42%, reflecting higher-than-normal inflationary headwinds and negative mix more than offsetting the benefits from cost savings.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

com CLX-F Page 6 of 17 Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, regarding the acquisition of GOJO, and any such forward-looking statements involve risks, assumptions and uncertainties.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed.

SEC original ↗Clorox — Earnings release (8-K exhibit)EX-99Aug 3, 2026

From time to time, the Company is subject to various legal proceedings, claims and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements (including costs connected to the transition and unwinding of certain supply and manufacturing relationships), product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters.

SEC original ↗Clorox — 10-Q Quarterly report10-QApr 30, 2026

With respect to these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, either individually or in the aggregate, on the Company s condensed consolidated financial statements taken as a whole.

SEC original ↗Clorox — 10-Q Quarterly report10-QApr 30, 2026

Documents

Earnings deck slides

0 decks with slide view

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Clorox — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Competitors

Competitors & peers

Named in the company’s own filings

Walmart (WMT)“Customers Net sales to the Company s largest customer, Walmart Stores, Inc.”

Filings

30 documents

Earnings releases

14 documents

Presentations

8 documents

Transcripts

0 documents

No transcripts for Clorox are held in this edition of the library.

Mentioned by

8 companies

Other tracked companies whose held documents mention Clorox by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.